TrialSignal
Clinical trial intelligence report
Tailored Activity to Improve Affect in Dementia
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT00259467-Jul 28, 2026
NCT ID
NCT00259467
Status
COMPLETED
Phase
Phase 1
Sponsor
Thomas Jefferson University
Executive brief
Investment-Ready Snapshot
The Tailored Activity to Improve Affect in Dementia (TAP) project, sponsored by Thomas Jefferson University, focuses on a behavioral intervention designed to enhance the quality of life for dementia patients and alleviate caregiver burden. Given the increasing prevalence of dementia, particularly Alzheimer's disease, this intervention addresses a significant unmet need in the market. The potential for scalability and integration into existing care frameworks could position this program favorably against traditional pharmacological treatments. However, competitive analysis should consider other behavioral and psychosocial interventions currently in development or practice. The results of this trial may inform future funding opportunities and partnerships, particularly in the realm of caregiver support and dementia care solutions.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT00259467
Indication
Alzheimer's Disease
Modality
behavioral intervention
Target
Behavioral intervention targeting depressive affect and agitated behaviors in dementia patients.
Intervention
Home-Based Behavorial Intervention
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.